These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology (ESC), European Atherosclerosis Society (EAS) and European Society of Hypertension (ESH)]. de Backer G; Graham I; Poole-Wilson P; Pyörälä K; Shepherd J; Wood D; Zanchetti A Rev Esp Cardiol; 1995 Dec; 48(12):773-80. PubMed ID: 8685497 [No Abstract] [Full Text] [Related]
4. [Prevention of coronary disease in clinical practice. Guidelines of the working group of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension]. Pyörälä K; de Backer G; Graham I; Poole-Wilson P; Wood D Arch Mal Coeur Vaiss; 1995 Oct; 88(10 Suppl):1493-542. PubMed ID: 8815824 [No Abstract] [Full Text] [Related]
5. [The biological bases for prevention]. Paoletti R; Poli A G Ital Cardiol; 1989 Sep; 19(9):763-9; discussion 778-86. PubMed ID: 2612822 [No Abstract] [Full Text] [Related]
6. [Can we reduce the cardiovascular risk in hypertensive patients?]. Plouin PF Arch Mal Coeur Vaiss; 1998 Sep; 91 Suppl():7-8; discussion 29-30. PubMed ID: 9805562 [No Abstract] [Full Text] [Related]
7. AHA and ACC outline approaches to coronary disease risk assessment. Morey SS Am Fam Physician; 2000 Apr; 61(8):2534, 2537-8, 2541-2. PubMed ID: 10794587 [No Abstract] [Full Text] [Related]
8. [Methods of influencing life style and risk factors]. Mancini M; Contaldo F; Cortese C; Farinaro E; Ferrara LA; Giumetti D; Panico S; Postiglione A; Riccardi G; Rivellese A G Ital Cardiol; 1989 Sep; 19(9):787-99; discussion 811-9. PubMed ID: 2612824 [No Abstract] [Full Text] [Related]
9. Hypercholesterolemia: a reversible risk factor for coronary heart disease. Mishkel MA CMAJ; 1989 Feb; 140(4):419. PubMed ID: 2644008 [No Abstract] [Full Text] [Related]
10. The management of hypercholesterolemia revisited. Wiggins BS Manag Care Interface; 2001 Jan; 14(1):58-66, 72. PubMed ID: 11214536 [TBL] [Abstract][Full Text] [Related]
11. Should cholesterol-lowering drugs be used routinely to treat moderate hypercholesterolemia in patients with serum cholesterol levels of 6.20 to 6.85 mmol/L (240 to 265 mg/dL). An affirmative view. Crouch MA J Fam Pract; 1988 Jun; 26(6):665-70. PubMed ID: 3379369 [No Abstract] [Full Text] [Related]
12. [Effectiveness of the 5-year program of multi-factorial prevention of ischemic heart disease in men]. Meĭmanaliev TS; Shleĭfer EA; Madaminov IaK; Gil'fanova VSh; Aĭtmurzaeva GT; Finger EM; Ismailova ChS; Koshaliev EK; Iaroslavtseva OS; Podgurskaia LP Sov Med; 1990; (12):57-9. PubMed ID: 2151491 [No Abstract] [Full Text] [Related]
13. [Possibilities and strategies for prevention of ischemic heart disease. Risk factors, trials, mass and individual strategies]. Menotti A G Ital Cardiol; 1989 Sep; 19(9):770-7; discussion 778-86. PubMed ID: 2612823 [No Abstract] [Full Text] [Related]
14. Hypercholesterolemia. Is lipid-lowering worthwhile for older patients? Deedwania PC Geriatrics; 2000 May; 55(5):22-8. PubMed ID: 10826262 [TBL] [Abstract][Full Text] [Related]